Clinical Trial Update: Analysis of Screen-detected Lung Cancers' Genomic Traits

View source ↗

Summary

An ongoing clinical trial led by University College London investigates the genomic traits of screen-detected lung cancers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University College, London | Conditions: Lung Cancer | Status: RECRUITING